The DZNE is promoting a series of lectures and concerts to drive attention to the link between brain plasticity and high-end mental endeavours such as arts and music, which could positively influence the course of neurodegeneration.   What happens in your brain…

Care strategies for people with dementia - attitudes, models, implementation. This is the title of the 2nd annual meeting (meeting language is German) of the German Center for Neurodegenerative Diseases (DZNE) at the site in Witten, to which we would like to…

The conference "Ageing and Neurodegeneration" is co-organised by DZNE, the German Center for Neurodegenerative Diseases and the Max Planck Institute for Biology of Ageing. It brings together cutting edge scientific expertise to create a forum for a high-level…

Targets for Alzheimer therapy

Bonn, April 6th, 2011. The German Centre for Neurodegenerative Diseases (DZNE) is an attractive address for top scientists from around the world – 53% of the scientific appointments at the DZNE in Bonn are of international origin. Also the US-American Walker…

In June 2010, scientists from the DZNE, the Canadian Institutes of Health Research (CIHR) and the Medical Research Council (MRC, UK) launched “Centers of Excellence in Neurodegeneration” (COEN). From now on, the initiative has its own website. Further…

Munich/Bonn, 2md February 2011. Scientists at the German Center for Neurodegenerative Diseases (DZNE) and the Ludwig-Maximilians Universität Munich have found a promising approach for a possible treatment of so-called frontotemporal dementia, an Alzheimer-like…

Zuzana Šišková, scientist in the group of Stefan Remy at the DZNE and the Department of Epileptology at the University Hospital of Bonn, received a Humboldt Research Fellowship for Postdoctoral Researchers. With the award, she will investigate how nerve cells…

Scientists from Germany, UK and Italy identify a molecular switch that leads to a sustained increase of calcium in nerve cells and plays a crucial role in the formation of memory and addictive behaviors.

Scientists from Berlin, Bonn and Dundee show in animal models that the diabetes drug Metformin has an effect against one of the main causes of the Alzheimer’s disease.